AllMed Announces PeerScore Solutions for Hospital P... ( Customized services meet or exceed Th...)

AllMed Announces PeerScore Solutions for Hospital Peer Review

Date:1/13/2009

Customized services meet or exceed The Joint Commission's OPPE and FPPE standards

PORTLAND, Ore., Jan. 13 /PRNewswire/ -- AllMed Healthcare Management today announced two new services to help hospitals and ambulatory surgical centers (ASCs) monitor and measure the performance of their physicians, as well as meet accreditation standards. The two PeerScore(SM) services help hospitals meet ongoing professional practice evaluation (OPPE) and focused professional practice evaluation (FPPE) required by The Joint Commission.

"Besides the obligatory analysis of any sentinel event, today's hospitals and ACSs also face tighter peer-review standards, increased scrutiny of doctors' performance and the demand for consistent and repeatable credentialing, privileging, proctoring processes," said Andrew G. Rowe, CEO. "Our PeerScore services offer a convenient and cost-effective way for them to implement unbiased, consistent and repeatable processes for both ongoing and focused evaluations."

Common PeerScore Features

AllMed's PeerScore solutions help hospitals and ASCs meet or exceed the intent of The Joint Commission's OPPE and FPPE standards by emphasizing physician education and performance improvement. Both services help them monitor doctors' performance across specialties and departments and, by removing conflict of interest to ensure objective, continuous, consistent and reliable evaluations of practitioner performance. PeerScore uses board-certified, actively practicing physicians who possess the same credentials and work in similar practice settings to review each physician or case.

PeerScore OPPE

PeerScore OPPE(SM) moves hospitals beyond the reactive analysis focused mostly on isolated sentinel events, by offering systematic and proactive reviews of physicians' work on an ongoing basis. By deploying PeerScore OPPE, hospitals and ASC groups can monitor
'/>"/>

SOURCE AllMed Healthcare Management
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. AllMed Announces Annual Hospital Peer Review Survey Results
2. AllMed Survey of Hospital Quality Managers Shows Much Room for Improvement in Peer Review
3. ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd.
4. Nationwide Medical/Surgical Announces They Will Carry Flu Vaccine
5. North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential
6. QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation
7. QLT announces Visudyne(R) sales for fourth quarter and fiscal year 2008
8. Ranir, LLC Announces the Acquisition of Placontrol, Inc.
9. Varian Medical Systems Announces Net Orders Growth Estimates for the First Quarter of Fiscal Year 2009
10. Mindray Announces Preliminary 2008 Operating Results
11. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections

Post Your Comments:

(Date:12/5/2009)... advanced Technology Center helps companies develo...y available to the lab allows it to work in a vari... relating to cleaning parts, process development, ...s) December 5, 2009 -- Midbrook, Inc , a Jackson,...gy center laboratory that performs a wide variety ...

(Date:12/4/2009)...ent Trust Inc. (NYSE: CRE ) ("Care" or the "Com... has declared a dividend of $0.17 per share of com..., 2009 to common shareholders of record on Decembe... Care Investment Trust Inc. is a real estate inves...related real estate and commercial mortgage debt. ...

(Date:12/4/2009)...lthcare Trust of America, Inc. ("HTA"), a self-man...nounced the execution of a purchase and sale agree...rtfolio located in San Angelo, Texas, Corsicana, T...0,500,000. The closing of the acquisition is subj... ,, The approximately 92,500 square foot portfolio...

(Date:12/4/2009)...se to the U.S. Justice Department Drug Enforcement...methyltestosterone, and 19-nor-4,9(10)-androstadie...ed Substances Act (CSA), John Gay, executive direc...PA), the oldest and largest trade association rep...upplements and other natural products, issued the ...

(Date:12/4/2009)...re recruited annually to participate in clinical t... Protection (AHRP), and most will be compensated f...ns view payments to volunteers as compensation for...ial risks related to participating in the experime...very different view of clinical trial compensation...

Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2 Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3 Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2 Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2 Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2 Health News:Human guinea pigs wary of high-paying medical trials 2

[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification [0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share [0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana [0] Natural Products Association Issues Statement on DEA's Steroid Classification Action [0] Human guinea pigs wary of high-paying medical trials

...are unregulated and could be dangerous, agency say...- U.S. health officials warned Wednesday about so ... (BHRT) drugs, an increasing popular alternative t...t of them Internet-based, saying that claims touti...

...nts, needs from product design and development thr...AN FRANCISCO, Jan. 9 Hiemstra Product Development..., announced today that it has,received Food and Dr...edical devices in its 750 sq. ft., class 10,000,CE...

... 9 TeamStaff, Inc.,(Nasdaq: TSTF ) a national pr...ervices, today announced that on January 4, 2008, ...Nasdaq Stock Market ("Nasdaq"),indicating that Tea...aff informing it that for 30 consecutive business,...

...steroids, insulin don,t combat mortality , ...tudies on the treatment of septic shock question t...roids, intensive insulin therapy or with the synth...found no improvement in survival rates. , The seco...

...few weeks since you made that New Years resolution...ns to skip days maybe even weeks. , You know al... to the weight loss, which would obviously be nice...TV instead of going for a short jog is just too gr...

...n. 9 The 11th annual LSU,Health Care Services Div...led "Eliminating Disparities and Improving Access ..., 2008, at the Holiday Inn,Select, 4728 Constituti...e presenters will show how redesign and,improvemen...

FDA Warns Against Bio-Identical Hormone Therapy Hiemstra Approved to Manufacture Medical Devices in New CER TeamStaff Receives Nasdaq Determination Letter Standard Septic Shock Treatments Ineffective Exercising judgment: The psychology of fitness LSU Forum Examines Health-Care Disparities and Access to Care

(Date:12/4/2009)...Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ...leconference and webcast. Principal investigators...arfilzomib in relapsed and/or refractory multiple ...of Hematology (ASH) Annual Meeting. ,, The telecon...n Monday, December 7, 2009. The live webcast will...

(Date:12/4/2009)...4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefe...inst biological and chemical threats, announced to...s anthrax vaccine program showing that its lyophil...thrax vaccine is structurally stable and potent af...cluding 55 degrees C. The data were presented by ...

(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a biodefens...st biological and chemical threats, announced toda...y demonstrating the effectiveness of Valortim®...d White (NZW) rabbit. The data are being presente...Emergency Medical Countermeasures Enterprise (PHEM...

[0] Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference [0] PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop [0] PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop

...NGHAM, Ala., Oct. 12 BioCryst,Pharmaceuticals, In...itiated,enrollment of the pivotal trial of its lea...reatment of patients with cutaneous T-cell lymphom...prnh/20030414/BIOCRYSTLOGO ) The multinational t...ne,HCL treatment, will be conducted in accordance ...

...VILLE, Calif., Oct. 11 KineMed Inc., a,pathway-ba...ced today,presentation of data demonstrating the a...erve cells in the hippocampus, a part of the brain... of a partnered relationship in,indications discov...t in a,preclinical model. The findings were disclo...

Other Medicine Technology:BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL) 2 BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL) 3 BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL) 4 KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 2 KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 3

BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model

Deluxe

Wraparound Apron & Vest

Special Procedure Apron

Coat Apron

Medicine Products:

Deluxe Wraparound Apron & Vest Special Procedure Apron Coat Apron

AllMed Announces PeerScore Solutions for Hospital P...( Customized services meet or exceed Th...),Health